Last reviewed · How we verify
Zirconium Zr 89-DFO-YS5
Zirconium Zr 89-DFO-YS5 is a Small molecule drug developed by Robert Flavell, MD, PhD. It is currently in Phase 1 development. Also known as: (89)Zr-DFO-YS5, 89Zr DFO-YS5.
At a glance
| Generic name | Zirconium Zr 89-DFO-YS5 |
|---|---|
| Also known as | (89)Zr-DFO-YS5, 89Zr DFO-YS5 |
| Sponsor | Robert Flavell, MD, PhD |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Zirconium Zr 89-DFO-YS5 CI brief — competitive landscape report
- Zirconium Zr 89-DFO-YS5 updates RSS · CI watch RSS
- Robert Flavell, MD, PhD portfolio CI
Frequently asked questions about Zirconium Zr 89-DFO-YS5
What is Zirconium Zr 89-DFO-YS5?
Zirconium Zr 89-DFO-YS5 is a Small molecule drug developed by Robert Flavell, MD, PhD.
Who makes Zirconium Zr 89-DFO-YS5?
Zirconium Zr 89-DFO-YS5 is developed by Robert Flavell, MD, PhD (see full Robert Flavell, MD, PhD pipeline at /company/robert-flavell-md-phd).
Is Zirconium Zr 89-DFO-YS5 also known as anything else?
Zirconium Zr 89-DFO-YS5 is also known as (89)Zr-DFO-YS5, 89Zr DFO-YS5.
What development phase is Zirconium Zr 89-DFO-YS5 in?
Zirconium Zr 89-DFO-YS5 is in Phase 1.
Related
- Manufacturer: Robert Flavell, MD, PhD — full pipeline
- Also known as: (89)Zr-DFO-YS5, 89Zr DFO-YS5
- Compare: Zirconium Zr 89-DFO-YS5 vs similar drugs
- Pricing: Zirconium Zr 89-DFO-YS5 cost, discount & access